Welcome to our dedicated page for CVS HEALTH CORPORATION news (Ticker: $CVS), a resource for investors and traders seeking the latest updates and insights on CVS HEALTH CORPORATION stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CVS HEALTH CORPORATION's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CVS HEALTH CORPORATION's position in the market.
A recent CVS Health survey conducted by Morning Consult revealed that concerns about mental health are on the rise, surpassing levels seen during the COVID-19 pandemic. The survey found that two-thirds of adults are worried about their mental health or that of their loved ones. Concerns about mental health have increased by 15% since 2020, with 77% of adults viewing it as a top issue alongside the economy. Parents are particularly concerned about their children's mental well-being. The survey also highlighted the impact of social media on mental health, with many adults turning to mental well-being apps and therapists for support. CVS Health remains committed to improving access to mental health care through both virtual and in-person services.
CVS Health (NYSE: CVS) will be represented by Chief Financial Officer Tom Cowhey at the Bank of America 2024 Healthcare Conference on May 14, 2024. The event will include a fireside chat with investors, which will be available via audio webcast on the CVS Health Investor Relations website for one year.
CVS Health reported total revenues of $88.4 billion in the first quarter of 2024, up 3.7% from the prior year. The company adjusted its full-year 2024 guidance for GAAP diluted EPS to at least $5.64 and Adjusted EPS to at least $7.00. The CEO expressed confidence in the company's long-term potential amid challenges in the Medicare Advantage segment.